Javed Butler

Javed Butler

Professor of Medicine

MBBS

University of Mississippi Medical Center, Jackson, MS, US

  • Twitter
  • OrcidID

Biography

Dr Javed Butler is President, Baylor Scott and White Research Institute, Dallas, TX and Professor of Medicine, University of Mississippi, Jackson, MS, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He has authored more than 900 peer-reviewed publications.

 

Read more

Media

Piotr Ponikowski, Shelley Zieroth, Javed Butler, et al

Shelley Zieroth, Javed Butler, Carolyn Lam, et al

Shelley Zieroth, Andrew JS Coats, Javed Butler, et al

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFpEF

Javed Butler,

Anushka Patel, Stephen Nicholls, Jeffrey Weitz, et al

Andrew JS Coats, Shelley Zieroth, Javed Butler, et al

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

AHA 2020 Discussion: Analysis from the EMPEROR-Reduced Study — Drs Javed Butler & Harriette Van Spall

Harriette Van Spall, Javed Butler,

AHA 2019: Update on the latest Heart Failure data

Marc P Bonaca, Javed Butler,

AHA 2018: EMPRISE Trial

Javed Butler,

Aha 2018: Should Cardiologists Be Following the New EASD/ADA Guidelines

Javed Butler, Carolyn Lam,

ESC 2018: Use of SGLT2 inhibitors in clinical practice to reduce CV mortality in patients with type 2 diabetes

Javed Butler, Stefan Anker,

Risk For Heart Failure Modulate The Effectiveness Of Empagliflozin ? with Javed Butler

Javed Butler,

Articles by Javed Butler, Professor of Medicine

Predictors of Post-discharge Mortality Among Patients Hospitalized for Acute Heart Failure

Ovidiu Chioncel, Sean P Collins, Stephen J Greene, et al

Citation: Cardiac Failure Review 2017;3(2):122–9.

DOI:

https://doi.org/10.15420/cfr.2017:12:1
Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes

Muhammad Shahzeb Khan, Javed Butler,

Published:

Citation: Cardiac Failure Review 2019;5(3):169–72.

DOI:

https://doi.org/10.15420/cfr.2019.06.R1
The Limitations of Symptom-based Heart Failure Management

Lampros Papadimitriou, Charles K Moore, Javed Butler, et al

Published:

Citation: Cardiac Failure Review 2019;5(2):74–7.

DOI:

https://doi.org/10.15420/cfr.2019.3.2